These results, taken together, demonstrate that TET1 stabilizes HIF1α by suppressing its FBW7γ-mediated K48-linked ubiquitination and proteasome degradation via the AKT/GSK3β pathway in thyroid cancer cells (Fig. 4M). Here, AKT1 is linked to thyroid cancer.